 | Up a level |
Sorbye, H; Hjortland, G O; Vestermark, L W; Sundlov, A; Assmus, J; Couvelard, A; Perren, A; Langer, S W (2024). NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasms. (In Press). Journal of neuroendocrinology, e13428. Wiley 10.1111/jne.13428
Galleberg, R B; Knigge, U; Tiensuu Janson, E; Vestermark, L W; Haugvik, S-P; Ladekarl, M; Langer, S W; Grønbæk, H; Österlund, P; Hjortland, G O; Assmus, J; Tang, L; Perren, Aurel; Sorbye, H (2017). Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas. European journal of surgical oncology EJSO, 43(9), pp. 1682-1689. Elsevier 10.1016/j.ejso.2017.04.010
Garcia-Carbonero, R; Sorbye, H; Baudin, E; Raymond, E; Wiedenmann, B; Niederle, B; Sedlackova, E; Toumpanakis, C; Anlauf, M; Cwikla, J B; Caplin, M; O'Toole, D; Perren, Aurel (2017). ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas. Neuroendocrinology, 103(2), pp. 186-194. Karger 10.1159/000443172
